414 related articles for article (PubMed ID: 16193681)
21. [Spatial contrast sensitivity in multiple sclerosis].
Vighetto A; Grochowicki M; Cousin J
Rev Neurol (Paris); 1990; 146(4):264-70. PubMed ID: 2359900
[TBL] [Abstract][Full Text] [Related]
22. Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial.
Beck RW; Kupersmith MJ; Cleary PA; Katz B
Ophthalmology; 1993 May; 100(5):691-7; discussion 697-8. PubMed ID: 8493012
[TBL] [Abstract][Full Text] [Related]
23. [Visual field defects in 169 cases of pituitary adenomas].
Shen MQ; Ye W; Zhang YY; Chen J
Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1074-9. PubMed ID: 20193428
[TBL] [Abstract][Full Text] [Related]
24. Asymptomatic visual field disturbances in multiple sclerosis patients without a history of optic neuritis.
Chorazy M; Drozdowski W; Sherkawey N; Mariak Z
Neurol Neurochir Pol; 2007; 41(3):223-8. PubMed ID: 17629815
[TBL] [Abstract][Full Text] [Related]
25. [Topography of early glaucomatous visual field defects in computerized perimetry].
Gramer E; Gerlach R; Krieglstein GK; Leydhecker W
Klin Monbl Augenheilkd; 1982 Jun; 180(6):515-23. PubMed ID: 7132176
[TBL] [Abstract][Full Text] [Related]
26. Visual field defects in selective amygdalohippocampectomy for hippocampal sclerosis: the fate of Meyer's loop during the transsylvian approach to the temporal horn.
Yeni SN; Tanriover N; Uyanik O; Ulu MO; Ozkara C; Karaağaç N; Ozyurt E; Uzan M
Neurosurgery; 2008 Sep; 63(3):507-13; discussion 513-5. PubMed ID: 18812962
[TBL] [Abstract][Full Text] [Related]
27. Fatigue effect within 10 degrees visual field in automated perimetry.
Fujimoto N; Adachi-Usami E
Ann Ophthalmol; 1993 Apr; 25(4):142-4. PubMed ID: 8484656
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of macular thickness measurements for detection of band atrophy of the optic nerve using optical coherence tomography.
Moura FC; Medeiros FA; Monteiro ML
Ophthalmology; 2007 Jan; 114(1):175-81. PubMed ID: 17070583
[TBL] [Abstract][Full Text] [Related]
29. Visual field defects and retinal nerve fiber layer defects in eyes with buried optic nerve drusen.
Katz BJ; Pomeranz HD
Am J Ophthalmol; 2006 Feb; 141(2):248-253. PubMed ID: 16458676
[TBL] [Abstract][Full Text] [Related]
30. The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.
Keltner JL; Johnson CA; Anderson DR; Levine RA; Fan J; Cello KE; Quigley HA; Budenz DL; Parrish RK; Kass MA; Gordon MO;
Ophthalmology; 2006 Sep; 113(9):1603-12. PubMed ID: 16949445
[TBL] [Abstract][Full Text] [Related]
31. Optic neuritis: correlation of pain and magnetic resonance imaging.
Fazzone HE; Lefton DR; Kupersmith MJ
Ophthalmology; 2003 Aug; 110(8):1646-9. PubMed ID: 12917187
[TBL] [Abstract][Full Text] [Related]
32. [Retrobulbar optic neuritis and multiple sclerosis].
Kaźmierczak K; Malukiewicz-Wiśniewska G
Klin Oczna; 2006; 108(7-9):285-9. PubMed ID: 17290825
[TBL] [Abstract][Full Text] [Related]
33. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial.
Newman NJ; Biousse V; Newman SA; Bhatti MT; Hamilton SR; Farris BK; Lesser RL; Turbin RE
Am J Ophthalmol; 2006 Jun; 141(6):1061-1067. PubMed ID: 16765674
[TBL] [Abstract][Full Text] [Related]
34. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group.
Keltner JL; Johnson CA; Spurr JO; Beck RW
Arch Ophthalmol; 1993 Feb; 111(2):231-4. PubMed ID: 8431161
[TBL] [Abstract][Full Text] [Related]
35. [Quality of life in visual disturbances in multiple sclerosis].
Opara J; Szwejkowski W; Brola W
Wiad Lek; 2008; 61(1-3):62-6. PubMed ID: 18717046
[TBL] [Abstract][Full Text] [Related]
36. Component perimetry: a fast method to detect visual field defects caused by brain lesions.
Bachmann G; Fahle M
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2870-86. PubMed ID: 10967040
[TBL] [Abstract][Full Text] [Related]
37. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
Fisher JB; Jacobs DA; Markowitz CE; Galetta SL; Volpe NJ; Nano-Schiavi ML; Baier ML; Frohman EM; Winslow H; Frohman TC; Calabresi PA; Maguire MG; Cutter GR; Balcer LJ
Ophthalmology; 2006 Feb; 113(2):324-32. PubMed ID: 16406539
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of saccadic vector optokinetic perimetry: a method of automated static perimetry for children using eye tracking.
Murray IC; Fleck BW; Brash HM; Macrae ME; Tan LL; Minns RA
Ophthalmology; 2009 Oct; 116(10):2017-26. PubMed ID: 19560207
[TBL] [Abstract][Full Text] [Related]
39. Comparison of central and peripheral visual field properties in the optic neuritis treatment trial.
Keltner JL; Johnson CA; Spurr JO; Beck RW
Am J Ophthalmol; 1999 Nov; 128(5):543-53. PubMed ID: 10577521
[TBL] [Abstract][Full Text] [Related]
40. [Visual field changes secondary to vigabatrin treatment].
Mauri-Llerda JA; Iñiguez C; Tejero-Juste C; Santos-Lasaosa S; Escalza-Cortina I; Ascaso-Puyuelo J; Abad-Alegría F; Morales-Asín F
Rev Neurol; 2000 Dec 16-31; 31(12):1104-8. PubMed ID: 11205539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
